ERF — Eurofins Scientific SE Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapHigh Flyer

Annual income statement for Eurofins Scientific SE, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	5,439	6,718	6,712	6,515	6,951
Cost of Revenue
Gross Profit	1,413	1,902	1,513	1,364	1,552
Selling / General / Administrative Expenses
Depreciation and Amortization
Other Operating Expenses
Total Operating Expenses	4,415	5,245	5,675	5,673	5,934
Operating Profit	1,024	1,473	1,037	842	1,017
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	920	1,369	904	736	884
Provision for Income Taxes
Net Income After Taxes	707	1,043	683	568	687
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	540	783	610	310	406
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	505	749	581	257	353
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	3.43	5.03	3.51	2.91	3.5
Dividends per Share